Max Distler

Programmable Nanoparticle Assembly and Fine-Tuned Therapeutic Design | NU Ph.D. Candidate in Chemistry | Mirkin Lab

[Michelle Teplensky @DrMTeplensky]

📢Calling BME PhD & grad applicants 📢We want to meet you! 😊 Come learn about our graduate programs at @BU_Tweets @BUCollegeofENG @BostonU_BME at @BMESociety #BMES2023 this week! Talk to faculty & students, learn about our department's research🧪🧫, and join us at our reception!

[American Cancer Society @AmericanCancer]

The American Cancer Society is awarding 90 new Research and Career Development Grants totaling $45M, funding researchers at 67 institutions nationwide. These grantees are leading innovative discoveries that advance our mission to end cancer, for everyone. https://t.co/aCSLNkNykc

[Eric Topol @EricTopol]

Innovation in cancer vaccines to markedly increase cancer antigen-specific T cells and activation of these cells @natBME @CHADNANO @DrMTeplensky @MirkinGroupNU @NUFeinbergMed @IINanoNU https://t.co/rLXCM7OI4r

[Namrata Ramani @NamrataRamani]

So stoked our work is out in JACS today! A rapid, sensitive, and selective method for detecting biomolecules with implications in POC settings @DevleenaSamanta @sasha__nano

[tgsatnu @TGSatNU]

David Duowei Xu is a PhD candidate in @NUChemistry in @WeinbergCollege, focusing on luminescent materials on the molecular scale. David is passionate about sharing ideas and collaborating with other people in the field of chemistry.

Read more @ https://t.co/X4dul3Bazw.

[Max Distler @Max_Distler]

@nicolas_gerst Yes, that is correct. The SNA is a highly modular and therefore generalizable platform for vaccine design. All that would be required to target a different infectious disease is a simple switch of the protein component.